UCSF’s Peter Walter, PhD, is leading this effort with his collaborator, Dr. Aashish Manglik, to test and produce AeroNabs, a nasal spray or nebulizing inhaler that would act as a first line of defense against infection in the nose, throat and lungs, where the virus enters the body.